XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona Initiates Search for New CFO

Dentsply Sirona Initiates Search for New CFO

Glenn Coleman to Resign in November to Join Another Company

CHARLOTTE, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to assume an executive position at another public company. The Company has initiated a search process to identify its next CFO with the assistance of a leading executive search firm.

“On behalf of the entire Dentsply Sirona team, I want to extend our deepest gratitude to Glenn for his leadership and many contributions to our Company over the last two years,” said Simon Campion, President and Chief Executive Officer. “During his tenure, Glenn has been instrumental in implementing our business transformation plan, initiating our ERP modernization efforts and advocating for our Employee Resource Groups. I look forward to continuing to work closely with him as we prepare for an orderly transition of his responsibilities in the coming months.”

“While I am excited about this next phase of my career, it has been an absolute privilege to be part of the Dentsply Sirona leadership team, and I am entering this new chapter incredibly proud of what we have accomplished,” said Mr. Coleman. “I am confident that Dentsply Sirona is well positioned for success with a strong, aligned leadership team in place to see the Company through its transformation journey.”

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information:

Investors:

Andrea Daley

Vice President, Investor Relations



Press:

Marion Par-Weixlberger

Vice President, Public Relations & Corporate Communications

88



EN
20/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE

Dentsply Sirona to Participate in Upcoming Investor Conferences

Dentsply Sirona to Participate in Upcoming Investor Conferences CHARLOTTE, N.C., Aug. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 9:15 am ETBaird Global Healthcare Conference on September 10, 2024, at 9:40 am ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About...

 PRESS RELEASE

Dentsply Sirona Initiates Search for New CFO

Dentsply Sirona Initiates Search for New CFO Glenn Coleman to Resign in November to Join Another Company CHARLOTTE, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to assume an executive position at another public company. The Company has initiated a search process to identify its next CFO with the assistance of a leading executive search firm. “On behalf of the entire Dentsply Sirona team, I wan...

 PRESS RELEASE

Dentsply Sirona Reports Second Quarter 2024 Results and Announces Seco...

Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%)GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02)Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10)Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common stock in Q3 2024Second phase o...

Dentsply Sirona Inc.: Update to credit analysis

Our credit view of this issuer reflects its moderate financial leverage and its strong market position in the dental device industry, against its high reliance on distributors.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch